Press release
Pharmaceutical Glass Packaging Market to Reach USD 37.62 Billion by 2030 | DataM Intelligence
Pharmaceutical Glass Packaging Market
The increasing global pharmaceutical demand-driven by population aging, chronic disease prevalence, and heightened healthcare spending-is directly translating into higher adoption of glass packaging solutions. North America dominated the global market in 2023 with a 35.5% revenue share, while Asia Pacific is expected to record the fastest growth due to expanding generic drug production capacity and favorable regulatory frameworks.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/pharmaceutical-glass-packaging-market?utm_source=OpenPR&utm_campaign=Onkar
Key Highlights from the Report
➤ Global pharmaceutical glass packaging market forecasted to reach USD 37.62 billion by 2030 with 9.88% CAGR (2024-2030).
➤ North America held a dominant 35.5% share in 2023.
➤ Pharmaceutical glass bottles led the product segment, accounting for 34.2% of revenue.
➤ Generic drug type dominated the market with a 72.9% share in 2023.
➤ Type I borosilicate glass remained the preferred material for high‐durability and chemical resistance.
➤ Increasing focus on sustainable and RFID‐enabled smart packaging creates new growth avenues.
Market Segmentation
Product Insights
Among product categories, pharmaceutical glass bottles dominated global sales with a 34.2% share in 2023. Bottles are widely used for syrups, oral liquids, and reagents due to their chemical resistance and durability. Ampoules are projected to register the fastest growth rate, driven by demand for unit‐dose packaging and the ability to ensure excellent microbiological control and drug stability. Vials, made predominantly from Type I borosilicate glass, are expected to gain substantial traction with the surge in injectable biologic and vaccine products.
Material Insights
The market is segmented into Type I (Borosilicate), Type II (Treated Soda‐Lime), and Type III (Soda‐Lime). Type I borosilicate glass leads with outstanding thermal and chemical resistance, making it ideal for injectables and parenteral drugs. Type II glass, with enhanced chemical stability through surface treatment, is commonly used for buffered solutions and less reactive formulations, supporting cost‐effective production for generic pharma.
Drug Type Insights
The generic drug segment held over 72.9% of global revenue in 2023 and is expected to continue leading through 2030. Increased patent expiries and government encouragement for affordable healthcare are expanding generic drug production worldwide. This surge has amplified demand for glass bottles, vials, and ampoules that offer superior barrier strength and longer shelf life. Conversely, biologic drugs are driving specialty glass solutions designed to prevent surface degradation and delamination risks.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/pharmaceutical-glass-packaging-market?utm_source=OpenPR&utm_campaign=Onkar
Regional Insights
North America
North America commanded the largest market share of 35.5% in 2023, with the U.S. serving as the region's innovation hub for pharmaceutical glass development. High healthcare spending-projected to reach USD 6.2 trillion by 2028-drives pharmaceutical production and packaging consumption. Major glass manufacturers like Corning Incorporated and Gerresheimer AG continue to invest in high‐performance vial technologies, such as Corning's 2023 launch of Velocity Vials, offering greater hardness and reduced breakage risk.
Europe
Europe accounted for 19% of the global volume in 2023. The region's research‐driven pharmaceutical industry and focus on innovative biologic drugs necessitate advanced packaging solutions. However, energy constraints stemming from the Russia‐Ukraine crisis have temporarily affected glass production capacity, prompting manufacturers to prioritize efficiency and renewable energy integration in their facilities.
Asia Pacific
Asia Pacific is emerging as the fastest‐growing region, supported by rapid industrialization, rising health expenditure, and foreign investments in pharmaceutical manufacturing. Countries like India and China are enhancing domestic output of low‐cost generic drugs, driving demand for localized glass packaging production. Strategic partnerships such as the Corning - SGD Pharma joint venture in Telangana (India) to manufacture Velocity Vials underscore India's emergence as a regional production hub.
Middle East and Latin America
The Middle East and Latin America markets show promising potential due to growing government healthcare investments. Saudi Arabia's Vision 2030 health sector reforms and rising pharma investments are positively impacting the regional market. Brazil and Mexico also exhibit rising adoption of generic drugs, fueling market penetration for regional glass suppliers.
Market Dynamics
Market Drivers:
The expanding generic drug industry, increased use of injectable formulations, and strict drug stability regulations are key drivers. Glass offers superior chemical inertness and protection against oxygen and moisture, ensuring drug integrity and longer shelf life.
Market Restraints:
Production limitations related to energy consumption and susceptibility to breakage pose challenges. Glass delamination and chipping can impact biologic drug formulations, slightly restricting adoption in primary packaging applications.
Market Opportunities:
The shift toward eco‐friendly packaging and integration of smart technologies-including RFID tracking and tamper‐evident security-opens new avenues for value‐added glass solutions. Recyclability and reduced carbon footprint are making pharmaceutical glass a preferred choice for sustainable drug delivery.
Purchase This Exclusive Report at Just USD 5156 Only: https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-glass-packaging-market?utm_source=OpenPR&utm_campaign=Onkar
Reasons to Buy the Report
✔ Comprehensive analysis of market trends, growth drivers, and forecasts through 2030.
✔ In‐depth segmentation by product, material, drug type, and region.
✔ Insight into innovation trends including smart packaging and recyclable vials.
✔ Profiles of key industry players and technology advancements.
✔ Regional comparison to identify growth hotspots and investment opportunities.
Frequently Asked Questions (FAQs)
◆ How big is the global pharmaceutical glass packaging market in 2030?
◆ Which product segment dominates the pharmaceutical glass packaging industry?
◆ Who are the key players in the pharmaceutical glass packaging market?
◆ What is the expected CAGR for the market from 2024 to 2030?
◆ Which region is projected to witness the fastest growth through 2030?
Company Insights
Corning Incorporated
Nipro Corporation
SGD S.A.
Schott AG
Gerresheimer AG
Bormioli Pharma S.p.A.
West Pharmaceutical Services, Inc.
Stoelzle Oberglas GmbH
Shandong Medicinal Glass Co., Ltd.
Piramal Enterprises Ltd.
Ardagh Group S.A.
Şişecam Group
Recent Developments:
- In July 2023, Corning Inc. launched Viridian Vials, reducing CO2 emissions by 30% and improving filling‐line efficiency by 50%.
- In June 2023, SGD Pharma and Corning Inc. announced a joint venture to build a new glass tubing facility in Telangana, India, boosting pharma‐grade tubing production for Asian markets.
- In March 2023, Schott AG began local production of FIOLAX amber pharma glass in India, enhancing supply reliability and availability across Asia.
Conclusion
The global pharmaceutical glass packaging market is on a steady growth trajectory, powered by accelerating generic drug production, regulatory compliance demands, and advancements in drug delivery systems. With innovations in lightweight, low‐emission, and high‐performance vial technologies, manufacturers are addressing sustainability targets and quality expectations simultaneously. As the healthcare sector continues to evolve towards personalized medicine and biologic therapies, glass packaging will remain integral to ensuring drug safety, stability, and global supply chain integrity.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Glass Packaging Market to Reach USD 37.62 Billion by 2030 | DataM Intelligence here
News-ID: 4237791 • Views: …
More Releases from DataM Intelligence
U.S. Green Hydrogen Market to Reach USD 6.99 Billion by 2034 | DataM Intelligenc …
Rapid Expansion in Clean Energy and Industrial Decarbonization Sectors Drives Market Growth
According to DataM Intelligence, the U.S. Green Hydrogen Market was valued at USD 274.19 million in 2024, grew to USD 379.07 million in 2025, and is projected to soar to USD 6,993.64 million by 2034, expanding at a remarkable CAGR of 38.25% from 2025 to 2034. The rapid market growth is driven by the U.S. government's clean energy transition…
Bioresorbable Polymers Market to Reach USD 3.63 Billion by 2030 | DataM Intellig …
Rising Surgical Volumes and Medical Device Innovations Accelerate Market Growth
According to DataM Intelligence, the Global Bioresorbable Polymers Market was valued at USD 1.30 billion in 2022 and is projected to reach USD 3.63 billion by 2030, expanding at an impressive CAGR of 13.8% from 2023 to 2030. This strong growth is driven by increased surgical procedures worldwide, greater demand for biodegradable medical implants, and technological innovations in healthcare.
Bioresorbable polymers, also…
Agriculture Insurance Market to Reach USD 70.02 Billion by 2033 | DataM Intellig …
Rising Climate Uncertainties, Government Initiatives, and Technological Innovation Drive Growth
The Global Agriculture Insurance Market was valued at USD 41.47 billion in 2024 and is projected to reach USD 70.02 billion by 2033, expanding at a CAGR of 5.96% from 2025 to 2033, according to DataM Intelligence. The market growth is primarily driven by the escalating frequency of climate-related disasters such as floods, droughts, pest outbreaks, and hurricanes, which have intensified…
Magnesium Alloys Market to Reach USD 6.62 Billion by 2027 | DataM Intelligence
Rising Demand for Lightweight Materials and Defense Sector Expansion Drive Market Growth
The Global Magnesium Alloys Market is projected to be valued at USD 6.62 billion by 2027, growing at an impressive CAGR of 9.9% during the forecast period, according to DataM Intelligence. The market growth is fueled by the rising adoption of lightweight alloys in the automotive, aerospace, electronics, and defense industries. Magnesium alloys are widely recognized for their superior…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
